IJDMMS- International Journal for Doctor of Medicine and Medical Students (IJDMMS)

Offer for Students ₹ 999 INR ( offer valid till 31st December 2025)

Article Publish

13. Narrative Review of Jaundice in Clinical Practice Differential Diagnosis and Management Strategies

Authors & Affiliations :

1. Dr Turdaliev Samatbek [https://orcid.org/0000-0002-0836-0671]

2.Ali Salman

3. Manish Yadav

4. Sagupta Naz

( 1, Teacher, International Medical Faculty, Osh State University; Republic of Kyrgyzstan

2, Student, International Medical Faculty, Osh State University; Republic of Kyrgyzstan

3, Student, International Medical Faculty, Osh State University; Republic of Kyrgyzstan

4, Student, International Medical Faculty, Osh State University; Republic of Kyrgyzstan)

Abstract

Jaundice is a clinical syndrome characterized by yellow discoloration of the skin, sclerae, and mucous membranes resulting from redundant bilirubin accumulation in the bloodstream and tissues. It's an important individual indication representing a wide spectrum of underlying conditions affecting bilirubin metabolism, hepatic function, or bile excretion pathways. Jaundice may arise due to hemolytic processes, natural liver dysfunction, or obstruction of bile inflow. Accurate differentiation among these etiologies is pivotal because management strategies range from conservative medical therapy to surgical intervention and can significantly impact patient issues. Web of Journals 1
Bilirubin metabolism involves the breakdown of heme predominantly from ancient red blood cells, followed by hepatic uptake, conjugation, and excretion into corrosiveness. dislocation at any of these steps can lead to hostility. Traditional classification divides hostility into prehepatic( hemolytic), hepatic( hepatocellular), and posthepatic( obstructive) forms, each with distinct pathogenesis, clinical features, and remedial counteraccusations . Қазақша медицина 1
Despite its common circumstance, the discriminational opinion of hostility remains a clinical challenge due to overlapping symptoms and the involvement of different pathological processes. This composition reviews current substantiation on the discriminational individual approach to cases presenting with hostility and outlines substantiation- based remedial strategies tailored to the etiology of the condition.

Methods

Study Design and Information Sources
This research used a comprehensive literature review methodology. PubMed, MEDLINE, and clinical review papers were searched for studies and authoritative reviews related to hostility, discriminational opinion, and treatment modalities. Search terms included “ hostility discriminational opinion, ” “ hostility operation, ” “ hyperbilirubinemia, ” “ hemolytic hostility, ” “ hepatocellular hostility, ” and “ obstructive hostility. ” fresh sources included clinical guidelines and specialist review textbooks( e.g., StatPearls, MSD primers). NCBI 1
Addition and Rejection Criteria
To ensure applicability, papers published in English within the last 30 times were prioritized, with emphasis on high- impact journals, clinical reviews, and evidence- based guidelines. Case reports without broader clinical insights were excluded. Neonatal hostility papers were included only when applicable to general principles of hostility diagnostics and operation. Eco-Vector Journals Portal

Results
Pathophysiology of Jaundice
Jaundice reflects the imbalance between bilirubin product and elimination. Unconjugated bilirubin is lipid-soluble and travels bound to albumin to the liver, where hepatocytes take it up and conjugate it to glucuronic acid, forming conjugated bilirubin which is water-answerable and excreted into bile. Disruptions leading to elevated unconjugated or conjugated bilirubin situations give rise to the clinical hostility picture. Қазақша медицина

Table 1. Differential Diagnosis of Jaundice Based on Etiology, Laboratory Findings, and Clinical Features

Classification and Mechanisms
Prehepatic( Hemolytic) Jaundice
Prehepatic jaundice results from inordinate breakdown of red blood cells( hemolysis), overwhelming the liver’s capacity to conjugate bilirubin. Common causes include hemolytic anemias, sickle cell complaint, thalassemia, autoimmune hemolysis, andpost-transfusion responses. Clinically, cases may present with pale droppings, dark urine, anemia, and splenomegaly. Laboratory findings include elevated unconjugated bilirubin and reticulocytosis. PPT Online
Hepatic( Hepatocellular) Jaundice
Hepatic jaundice occurs due to intrahepatic dysfunction of bilirubin uptake, conjugation, or excretion caused by hepatocellular damage. Etiologies include viral hepatitis( A, B, C, etc.), alcoholic liver complaint, autoimmune hepatitis, medicine- induced liver injury,non-alcoholic adipose liver complaint, cirrhosis, and inheritable storage conditions. Cases frequently parade attendant symptoms of liver dysfunction, similar as fatigue, anorexia, right upper quadrant tenderheartedness, and coagulopathy. Serum liver function tests show elevated aminotransferases and varying degrees of cholestatic enzyme elevation. Web of Journals 1
Posthepatic( Obstructive) Jaundice
Posthepatic hostility is caused by inhibition of corrosiveness inflow in the biliary tree after conjugation, leading to elevated conjugated bilirubin. Causes include choledocholithiasis( common corrosiveness conduit monuments), strictures, excrescences( cholangiocarcinoma, pancreatic head carcinoma), and parasitic infestations. Symptoms frequently include pruritis, pale stools, dark urine, abdominal pain, and hostility. Imaging generally reveals biliary dilation. phosphogliv.ru
Clinical Presentation and Differential Diagnostic Strategy
The clinical evaluation begins with a detailed history and physical examination. material history includes onset and duration of hostility, alcohol use, drug history( e.g., hepatotoxins), trip history, blood transfusions, and family history of liver complaint. Physical examination focuses on scleral icterus, hepatomegaly, splenomegaly, ascites, skin changes( e.g., xanthomas), and signs of habitual liver complaint. immun.ru
A useful abstract frame for isolation includes

Laboratory analysis:

1. Complete blood count, reticulocyte count (evaluates hemolysis)

2. Total and direct bilirubin levels

3. Liver enzymes: AST, ALT, alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT)

4. Coagulation profile (INR) and albumin (assesses synthetic liver function)

5. Serologies for viral hepatitis and autoimmune markers. NCBI

2. Imaging modalities:

1. Ultrasonography as first-line imaging to assess biliary dilation.

2. CT scan or MRCP (Magnetic Resonance Cholangiopancreatography) for detailed anatomical evaluation.

3. ERCP (Endoscopic Retrograde Cholangiopancreatography) combines diagnosis and treatment for obstructive causes. MSD Manuals

3. Special investigations:

1. Liver biopsy when diagnosis remains unclear, particularly for hepatic causes.

2. Hemolysis work-up with direct Coombs, lactate dehydrogenase, haptoglobin. NCBI

Red flag symptoms such as fever, chills, and severe abdominal pain warrant urgent exclusion of acute cholangitis or complicated obstruction. PubMed

Diagnostic Algorithms

Algorithms for the diagnostic approach start with establishing whether jaundice is due to conjugated or unconjugated hyperbilirubinemia. An elevated unconjugated fraction suggests hemolytic or congenital disorders (e.g., Gilbert’s syndrome), while predominant conjugated elevation suggests hepatic or posthepatic causes. Imaging is prioritized when cholestasis is suspected. NCBI

Table 2. Etiology-Based Treatment Strategies for Jaundice

Treatment Strategies

Successful management of jaundice hinges on treating the underlying cause rather than the symptom itself. Below are evidence-based approaches to treatment across different etiologies.

Prehepatic Jaundice Treatment

Management focuses on treating the underlying hemolysis:

Autoimmune hemolytic anemia: corticosteroids, immunosuppressants.
Sickle cell disease: hydroxyurea, transfusions during crises.
Thalassemia: transfusion regimens and chelation.
Infections like malaria: appropriate antimalarial therapy. PPT Online

Supportive therapies may include folate supplementation and monitoring for gallstone formation, which can result from chronic hemolysis.

Hepatic Jaundice Treatment

Treatment depends on the specific liver pathology:

1. Viral hepatitis:

1. Hepatitis A and E: supportive care.

2. Hepatitis B and C: antiviral therapy (e.g., tenofovir, entecavir for HBV; direct-acting antivirals for HCV). Web of Journals

2. Alcoholic liver disease:

1. Abstinence from alcohol, nutritional support.

2. Corticosteroids for severe alcoholic hepatitis in selected cases.

3. Autoimmune hepatitis:

1. Immunosuppression with corticosteroids and azathioprine.

4. Drug-induced liver injury:

1. Discontinuation of the offending agent and supportive treatment.

For advanced liver disease with hepatic decompensation, liver transplant evaluation may be indicated. NCBI

Posthepatic (Obstructive) Jaundice Treatment

The primary goal is to relieve biliary obstruction:

Choledocholithiasis: ERCP with stone extraction.
Strictures: dilation or stent placement via ERCP.
Neoplasms: surgical resection (e.g., Whipple procedure for pancreatic head tumors) or palliative stenting.
Cholangitis: emergent biliary drainage with antibiotics. MSD Manuals

Symptomatic and Supportive Care

Pruritus from cholestatic jaundice is common and can be debilitating. Management includes:

Bile acid sequestrants (e.g., cholestyramine).
Antihistamines and rifampin for refractory pruritis.
Nutritional support and fat-soluble vitamin supplementation in chronic cholestasis. NCBI

Discussion

Key Findings

Jaundice, while a singular clinical manifestation, encompasses a broad differential diagnosis that requires careful integration of clinical history, laboratory data, and imaging studies. Classification into prehepatic, hepatic, and posthepatic categories assists clinicians in narrowing diagnostic possibilities and developing tailored treatment plans. Contemporary diagnostic strategies emphasize prompt identification of life-threatening conditions such as obstructive jaundice with cholangitis. PubMed

Clinical Implications

Early recognition of jaundice etiology enables appropriate and timely interventions, reducing morbidity and mortality.
Use of standardized diagnostic algorithms can enhance clinical decision-making.
Therapeutic strategies must be individualized based on etiology, patient comorbidities, and disease severity.

Limitations

This review is based on literature available in English which may exclude relevant non-English studies. Additionally, the complexity of rare causes of jaundice such as inherited cholestatic disorders is beyond the scope of this general review. SpringerLink

Conclusion

Jaundice represents a complex and clinically significant manifestation of a wide array of pathological processes involving bilirubin metabolism, hepatic function, and biliary excretion. Because it's a visible sign rather than a diagnosis in itself, its presence necessitates a structured and regular individual approach. Precision in discriminational diagnosis achieved through careful integration of clinical history, physical examination findings, biochemical profiles, and applicable imaging modalities is abecedarian to effective and timely operation. Failure to rightly identify the underpinning etiology may affect in delayed treatment, progression of complaint, and increased morbidity or mortality.
Clear isolation among hemolytic, hepatocellular, and obstructive causes of hostility remains the foundation of clinical decision- timber. Hemolytic hostility primarily requires identification and control of the underpinning cause of inordinate red blood cell destruction, while hepatocellular hostility authorizations targeted operation of liver injury, including antiviral, immunosuppressive, or probative curatives depending on the etiology. In discrepancy, obstructive hostility frequently demands prompt intervention to relieve biliary inhibition, exercising endoscopic, radiological, or surgical ways. The selection of these remedial strategies is largely dependent on accurate etiological bracket, complaint inflexibility, and case-specific factors.
Recent advancements in individual imaging, including high- resolution ultrasonography, glamorous resonance cholangiopancreatography, and endoscopic modalities, along with advancements in laboratory diagnostics and molecular testing, have significantly enhanced individual delicacy and case issues. Targeted medical curatives and minimally invasive interventions have further reduced complications and bettered vaticinations in numerous cases. nonetheless, substantial challenges persist, particularly in resource- limited settings where access to advanced imaging, specialized laboratory testing, and interventional procedures may be constrained. Addressing these difference through cost-effective individual algorithms, clinician training, and health system strengthening remains essential to perfecting global issues in cases presenting with hostility.

References:

1. Gondal B, Aronsohn A. A systematic approach to patients with jaundice. Semin Intervent Radiol. 2016;33(4):253–258. doi:10.1055/s-0036-1592331.

2. Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004;69(2):299–304.

3. Nishtar MW, Shamshad T, Ashraf MA, Javaid R. Jaundice: a basic review. Int J Res Med Sci. 2015;3(6):1313–1319.

4. Lee WM. Acute liver failure. N Engl J Med. 2003;329:1862–1872.

5. Tiribelli C, Ostrow JD. Molecular basis of bilirubin metabolism and toxicity. J Hepatol. 2005;43(1):156–166.

6. StatPearls Publishing. Jaundice. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544252/

7. European Association for the Study of the Liver (EASL). Clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237–267.

8. Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary cholangitis: 2018 practice guidance. Hepatology. 2019;69(1):394–419.

9. Liu JJ, Sun YM, Xu Y, et al. Pathophysiological consequences and treatment strategy of obstructive jaundice. World J Gastrointest Surg. 2023;15(7):1262–1276.

10. Schiff ER, Maddrey WC, Reddy KR. Schiff’s Diseases of the Liver. 12th ed. Hoboken: Wiley-Blackwell; 2017.

11. Goldman L, Schafer AI. Goldman-Cecil Medicine. 26th ed. Philadelphia: Elsevier; 2020.

12. Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 10th ed. Philadelphia: Elsevier; 2020.

13. Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison’s Principles of Internal Medicine. 21st ed. New York: McGraw-Hill; 2022.

14. Björnsson ES. Drug-induced liver injury: an overview over the most critical compounds. Arch Toxicol. 2015;89(3):327–334.

15. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008;359:1486–1500.

16. Feld JJ, Jacobson IM, Hézode C, et al. Sofosbuvir and velpatasvir for HCV infection. N Engl J Med. 2015;373:2599–2607.

17. Chapman RW, Fevery J, Kalloo AN, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51(2):660–678.

18. Boyer TD, Manns MP, Sanyal AJ. Zakim and Boyer’s Hepatology. 7th ed. Philadelphia: Elsevier; 2018.

19. Beuers U, Kremer AE, Bolier R, Elferink RPJO. Pruritus in cholestasis: facts and fiction. Hepatology. 2014;60(1):399–407.

20. Freeman ML. Role of ERCP in the diagnosis and treatment of biliary obstruction. Gastrointest Endosc. 2002;56(6 Suppl):S170–S174.

21. Tapper EB, Lok ASF. Use of liver imaging and biopsy in clinical practice. N Engl J Med. 2017;377:756–768.

22. Zoubek ME, Trauner M. Drug-induced cholestasis. Clin Liver Dis. 2014;18(2):215–230.

23. Poupon R. Primary biliary cholangitis: a 2017 update. J Hepatol. 2017;67(5):1115–1127.

24. Sherlock S, Dooley J. Diseases of the Liver and Biliary System. 12th ed. Oxford: Wiley-Blackwell; 2011.

25. Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology. 2009;50(1):291–308.

Google Sites

Report abuse